About this podcast
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
Episodes
The newest 20 of 43 episodes
- S2 E7: A Between the Biotech Waves Conversation with Bobby Gaspar · 59 min · Season 2 Episode 7Today’s episode features a remarkable leader in the field of gene therapy, Dr. Bobby Gaspar. With over 25 years of experience as a physician and scientist, Bobby has played a…
- S2 E6: A Between the Biotech Waves Conversation with Steve Paul · 56 min · Season 2 Episode 6I am thrilled to welcome Steve Paul to Between the Biotech Waves. With nearly 50 years of experience as a physician-scientist, Steve has made significant contributions to the…
- S2 E5: A Between the Biotech Waves Conversation with Kent Rogers · 1 h 1 min · Season 2 Episode 5Today, I are excited to welcome Kent Rogers, the Chief Executive Officer of EveryONE Medicines. Kent brings a wealth of experience to his new role, having held executive…
- Between the Biotech Waves - Sound Bite - Bill Hicks Co-Chair Life Sciences Practice Mintz · 23 minSound Bite with Bill Hicks looking at the market and financing in real time.
- Between the Biotech Waves - Sound Bite - Paul Matteis Equity Analyst Stifel · 26 minWelcome to a Between the Biotech Waves sound bite, a short podcast to provide insight into the rapidly changing biotech environment - I am pleased to welcome Paul Matteis…
- S2 E4: A Between the Biotech Waves Conversation with Dan Lynch · 1 h 1 min · Season 2 Episode 4In this episode, I am thrilled to welcome Dan Lynch, an Executive Venture Partner at Google Ventures and a seasoned leader in the biotechnology sector. Since joining GV in 2021…
- S2 E3: A Between The Biotech Waves Conversation with Stan Crooke, Ionis & N-Lorem Founder · 1 h 4 min · Season 2 Episode 3In today's episode, I am honored to welcome Stanley Crooke, the founder and CEO of Ionis Pharmaceuticals the first and leading antisense oligonucleotide biotech and founder, CEO…
- S2 E2: A Between the Biotech Waves Conversation with Peter Barrett · 54 min · Season 2 Episode 2Welcome to ‘Between the Biotech Waves,’ the podcast where we navigate the dynamic world of biotechnology and explore the minds driving its innovation. I’m your host, Nessan…
- S2 Episode 1: A conversation with Matt Porteus · 55 min · Season 2 Episode 1Now that JPM '25 is behind us, where the weather was great but the mood was somber, back to podcasting! Welcome back to 'Between the Biotech Waves,' the podcast where we explore…
- Episode 35: A Between the Biotech Waves Conversation with Mike Curtis, President & CEO of eGenesis · 1 h 5 min · Season 1 Episode 35Welcome back to Between the Biotech Waves. I am sorry for the lack of episodes over the past few months, unfortunately life threw me a curve ball that I have been taking care of…
- Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics · 1 h 4 min · Season 1 Episode 33Today I am talking to Eliot Forster xCEO of F-star Therapeutics. Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently…
- Episode 32: The Triplet Therapeutics story, from concept to birth, life & death. · 1 h 45 min · Season 1 Episode 32Today we have an unusual (& long) podcast where we talk to key members of the Triplet Therapeutics management team. Triplet was founded to develop antisense oligonucleotides…
- Episode 30: A Between the Biotech Waves conversation with Barry Greene, CEO of Sage Therapeutics · 46 min · Season 1 Episode 30Today we are talking to Barry Greene, CEO of Sage Therapeutics. Barry has had an amazing career spanning over 30 years in the biotech industry. Prior to Sage Barry was President…
- Episode 31: A Between the Biotech Waves Conversation with Tim Yu · 56 min · Season 1 Episode 31Today we are talking to Tim Yu. Tim is attending physician at the division of genetics and genomics at Boston Children’s Hospital and assoc prof of Pediatrics at Harvard Medical…
- Episode 28 A Between the Biotech Waves Conversation with Rachel Meyers · 58 min · Season 1 Episode 28Today we are talking to Rachel Meyers. Rachel was most recently the CSO of Faze Medicines a company she launched with TRV to focus on the regulation of biomolecular condensates…
- Episode 29: A Between the Biotech Waves conversation with Joel Marcus, Founder & Exec Chair of Alexandria Real Estate · 53 min · Season 1 Episode 29Today we are talking to Joel Marcus. He has shaped the life sciences industry through ARE from the buildings we use to venture and fund investing. His impact can be directly seen…
- Episode 27 A Between the Biotech Waves Conversation with Aoife Brennan, CEO of Synlogic · 1 h 6 min · Season 1 Episode 27Today we are talking to Aofie Brennan, president and CEO of Synlogic. Aoife was trained as a doctor at Trinity College Dublin following which she moved to the US. After…
- Episode 26: A Between the Biotech Waves conversation with Drew Weissman · 57 min · Season 1 Episode 26Today we are talking to Drew Weissman. Drew is the Roberts Family Professor in Vaccine Research at Perelman School of Medicine and Director of the Penn Institute for RNA…
- Episode 25: A Between the Biotech Waves conversation with Rodolphe Barrangou, the Todd R Klaenhammer Distinguished Professor at NC State University. · 1 h 0 min · Season 1 Episode 25Today we are talking to Rodolphe Barrangou. Rodolphe is the Todd R Klaenhammer Distinguished Professor at NC State University. He is a scientist entrepreneur who has co-founded a…
- Episode 24: A Between the Biotech Waves conversation with John Hoffman, managing director & head of healthcare equity capital markets at Credit Suisse · 52 min · Season 1 Episode 24I am delighted to welcome back John Hoffman to Between the Biotech Waves. John is managing director & head of healthcare equity capital markets at Credit Suisse. In mid 2022 John…
